tiprankstipranks
Trending News
More News >
Imunon (IMNN)
NASDAQ:IMNN

Imunon (IMNN) Stock Statistics & Valuation Metrics

Compare
1,274 Followers

Total Valuation

Imunon has a market cap or net worth of $25.61M. The enterprise value is $18.48M.
Market Cap$25.61M
Enterprise Value$18.48M

Share Statistics

Imunon has 17,541,733 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding17,541,733
Owned by Insiders4.51%
Owned by Institutions0.07%

Financial Efficiency

Imunon’s return on equity (ROE) is -4.39 and return on invested capital (ROIC) is -355.38%.
Return on Equity (ROE)-4.39
Return on Assets (ROA)-1.92
Return on Invested Capital (ROIC)-355.38%
Return on Capital Employed (ROCE)-3.88
Revenue Per Employee0.00
Profits Per Employee-744.81K
Employee Count25
Asset Turnover0.00
Inventory Turnover0.00

Valuation Ratios

The current PE Ratio of Imunon is -0.74. Imunon’s PEG ratio is -0.07.
PE Ratio-0.74
PS Ratio0.00
PB Ratio37.36
Price to Fair Value3.25
Price to FCF-1.26
Price to Operating Cash Flow-1.07
PEG Ratio-0.07

Income Statement

In the last 12 months, Imunon had revenue of 0.00 and earned -18.62M in profits. Earnings per share was -1.72.
Revenue0.00
Gross Profit0.00
Operating Income-19.13M
Pretax Income-18.62M
Net Income-18.62M
EBITDA-17.98M
Earnings Per Share (EPS)-1.72

Cash Flow

In the last 12 months, operating cash flow was -15.83M and capital expenditures -277.44K, giving a free cash flow of -16.11M billion.
Operating Cash Flow-15.83M
Free Cash Flow-16.11M
Free Cash Flow per Share-0.92

Dividends & Yields

Imunon pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share
Dividend Yield
Payout RatioN/A
Free Cash Flow Yield
Earnings Yield

Stock Price Statistics

Beta-0.16
52-Week Price Change26.96%
50-Day Moving Average1.03
200-Day Moving Average0.96
Relative Strength Index (RSI)52.73
Average Volume (3m)22.12M

Important Dates

Imunon upcoming earnings date is Aug 13, 2025, TBA Not Confirmed.
Last Earnings DateMay 12, 2025
Next Earnings DateAug 13, 2025
Ex-Dividend Date

Financial Position

Imunon as a current ratio of 1.67, with Debt / Equity ratio of 223.01%
Current Ratio1.67
Quick Ratio1.67
Debt to Market Cap0.00
Net Debt to EBITDA0.26
Interest Coverage Ratio0.00

Taxes

In the past 12 months, Imunon has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00

Enterprise Valuation

Imunon EV to EBITDA ratio is -0.50, with an EV/FCF ratio of -0.48.
EV to Sales0.00
EV to EBITDA-0.50
EV to Free Cash Flow-0.48
EV to Operating Cash Flow-0.48

Balance Sheet

Imunon has $2.87M in cash and marketable securities with $1.01M in debt, giving a net cash position of -$1.86M billion.
Cash & Marketable Securities$2.87M
Total Debt$1.01M
Net Cash-$1.86M
Net Cash Per Share-$0.11
Tangible Book Value Per Share$0.29

Margins

Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%

Analyst Forecast

The average price target for Imunon is $14.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$14.00
Price Target Upside858.90% Upside
Analyst ConsensusModerate Buy
Analyst Count2
Revenue Growth Forecast
EPS Growth Forecast24.16%

Scores

Smart Score7
AI Score41
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis